Opatrilova Radka, Cernikova Aneta, Coufalova Lenka, Dohnal Jiri, Jampilek Josef
Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
ScientificWorldJournal. 2013 Dec 18;2013:787283. doi: 10.1155/2013/787283. eCollection 2013.
This study is focused on in vitro permeation of the original Czech compound, a skin/mucosa tissue regeneration promoter, known under the international nonproprietary name "alaptide," in micronized and nanonized forms. Alaptide showed a great potential for local applications for treatment and/or regeneration of the injured skin. The above mentioned technological modifications influence the permeation of alaptide through artificial or biological membranes, such as PAMPA or skin. The permeation of micronized and nanonized form of alaptide formulated to various semisolid pharmaceutical compositions through full-thickness pig ear skin using a Franz cell has been investigated in detail. In general, it can be concluded that the nanonized alaptide permeated through the skin less than the micronized form; different observations were made for permeation through the PAMPA system, where the micronized form showed lower permeation than the nanonized alaptide.
本研究聚焦于原捷克化合物(一种皮肤/黏膜组织再生促进剂,国际非专利名称为“alaptide”)的微粉化和纳米化形式的体外渗透。Alaptide在局部应用于治疗和/或再生受损皮肤方面显示出巨大潜力。上述技术改性影响alaptide通过人工或生物膜(如PAMPA或皮肤)的渗透。已详细研究了通过Franz扩散池将微粉化和纳米化形式的alaptide配制成各种半固体制剂后通过猪耳全层皮肤的渗透情况。一般而言,可以得出结论,纳米化alaptide透过皮肤的量少于微粉化形式;对于通过PAMPA系统的渗透有不同观察结果,其中微粉化形式的渗透率低于纳米化alaptide。